ASCENDIS PHARMA A/S shareholders Q3 2023

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 164 filers reported holding ASCENDIS PHARMA A/S in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.6%.

ASCENDIS PHARMA A/S shareholders Q3 2023
NameSharesValueWeighting ↓
Newbridge Financial Services Group, Inc. 25$2,3410.00%
Bell Investment Advisors, Inc 42$3,9330.00%
MACKENZIE FINANCIAL CORP 4,653$409,0450.00%
BELLEVUE ASSET MANAGEMENT, LLC 15$1,4040.00%
ProShare Advisors LLC 3,731$349,3710.00%
BlackRock Inc. 333,566$31,235,1210.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 57,000$5,337,4800.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 34,500$3,230,5800.00%
PNC FINANCIAL SERVICES GROUP, INC. 16,225$1,519,3090.00%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 25,573$2,394,6560.00%
Russell Investments Group, Ltd. 7,374$690,5010.00%
BARCLAYS PLC 17,482$1,6370.00%
Quent Capital, LLC 38$3,5580.00%
JPMORGAN CHASE & CO 140,376$13,144,8080.00%
Cresset Asset Management, LLC 2,605$243,9320.00%
Tower Research Capital LLC (TRC) 328$30,7130.00%
HOEY INVESTMENTS, INC 24$2,2480.00%
JANE STREET GROUP, LLC 24,717$2,314,5000.00%
CREDIT SUISSE AG/ 8,932$836,3920.00%
GTS SECURITIES LLC 7,300$683,5720.00%
External links

This page lists ASCENDIS PHARMA A/S's shareholders in Q3 2023. To view ASCENDIS PHARMA A/S's shareholder history, click here.